Resources

Evan Sisson, PharmD, MHA, CDE, assistant professor at the Virginia Commonwealth University’s School of Pharmacy, outlines current thinking on the best LDL levels for our patients, and agrees with Steve that it is very confusing. There are many risk factors to be taken into account and we do not yet …

Evan Sisson answers the question: If you could have any LDL you wanted, irregardless of any disease, what would you want it to be? More videos with Evan Sisson: Evan Sisson, PharmD, MHA, CDE, Introduction Evan Sisson, PharmD, Q1: What Are the Current Guidelines on Lipid Treatment? Evan Sisson, PharmD, …

Evan Sisson talks about past concerns around statin risk and notes that there are many trials which have shown that statins, on their own, do not increase CV risk. However, he emphasizes that most of our patients with metabolic disease don’t just take a statin but are on other prescription …

Evan Sisson, notes that, even in the recent past, drug therapy was frequently “one-size-fits-all.” But now, newer agents are coming out that target other matebolic places which can affect LDL cholesterol in many different ways. As the medical community learns more about these other mechanisms, more tailored treatments may become …

Evan Sisson talks about how the foundation of his approach to treating hyperlipidemia with statins is actually lifestyle modification. He notes, however, that patients “can figure out how to out-eat any statin we can give them,” so the best programs are those that involve a team approach. That way, the …

A recent study published online in October 2012 in the British Journal of Nutrition (and reported on in Diabetes In Control) attempted to address the issue of how timing of exercise relative to meal ingestion influences substrate balance and metabolic responses1. In that study, ten sedentary, overweight men with a …

  Dexcom G4 Platinum CGM Approved    Dexcom has announced that the FDA has approved its G4 Platinum continuous glucose monitor (CGM). Clinical studies report up to approximately 19% improvement in overall accuracy compared to the Seven Plus, and approximately a 30% improvement in accuracy in the hypoglycemia range. Unlike …

In a breakthrough that signifies a move toward a cure for type 1 diabetes, Australian researchers have identified stem cells in the pancreas that can be turned into insulin-producing cells….

Within a year, patients with type 2 diabetes who were obese or of normal weight demonstrated an increased risk for all-cause mortality compared with patients whose BMI was in the overweight range….

Participants who ate carbohydrates mostly at dinner showed lower hunger scores compared with those who ate carbohydrates throughout the day….